5Chen Y,McCall TW,Baichwal AR,et al.The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms[J].J Controled.Release,1999,59:33-41.
6Betz G,Burgin PJ,Leuenberger H.Power consumption measurement and temperature recording during granulation[J].Int J Pharm,2004,272 (1-2):137-149.
7Agatonovic-Kustrin S,Alany RG.Role of genetic algorithms and artificial neural networks in predicting the phase behavior of colloidal delivery systems[J].Pharm Res,2001,18 (7):1049-1055.
8Turkoglu M,Aydina I,Murray M,et al.Modeling of a rollercompaction process using neural networks and genetic algorithms[J].Eur J Pharm Biopharm,1999,48:239-245.
9Agatonovic-Kustrin S,Wu V,Rades T,et al.Powder diffractometric assay of two polymorphic forms of ranitidine hydrochloride[J],Int J Pharm,1999,184:107-114.
10Kachrimanis K,Karamyan V,Malamataris S.Artificial neural networks (ANNs) and modeling of powder flow[J].Int J Pharm,2003,250:13-23.
